S&P 500
7,582.20
+0.03%
Dow Jones
51,018.80
+0.58%
Nasdaq 100
30,344.40
+0.25%
Russell 2000
2,916.31
-0.54%
FTSE 100
10,378.60
-0.32%
Nikkei 225
66,231.90
+0.67%

Health and Healthcare

Pfizer (PFE): Viagra Can Make Men Hard Of Hearing

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Pfizer (PFE) has a new ad campaign for its erectile dysfunction drug Viagra. The marketing message is all over TV and in little video clips online. Reuters.com appears to have one of the ads on every page. It is an nauseating vignette of several men, about 50 years old, singing the praises of the ED-drug while playing a guitar, piano, and bass. "Viva Viagra" indeed.

Now word comes that Viagra and other ED drugs can make some men hard of hearing. That may be a blessing when one of the "Viva Viagra" ads comes onto a TV or PC screen.

In an alert from FDA Medwatch, the agency wrote that it had informed healthcare professionals of reports of sudden decreases or loss of hearing following the use of PDE5 inhibitors Viagra, Levitra, and Cialis for the treatment of erectile dysfunction. In some cases, the sudden hearing loss was accompanied by tinnitus and dizziness.

Perhaps Pfizer’s investors will be listening for news of the next Viagra side-effect.

Douglas A. McIntyre

Follow 24/7 Wall St. on Google
Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Trey Thoelcke |

Teva Secures Rights to Launch Generic Viagra

ThinkstockPfizer Inc.’s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020,…

Paul Ausick |

Sears.com Sold Erectile Treatment With Viagra Ingredients

U.S. Food & Drug AdministrationA purported herbal sexual health supplement called O.M.G. has been found by the U.S. Food and…

Douglas A. McIntyre |

VIVUS Looking to Profit from Obesity and Sexual Dysfunction

by H.S. AyoubBioHealthInvestor.com Unless you have been under a rock, and not under a bed cover, you have probably heard…

Will Consumers Trust Generic Viagra?
Jon C. Ogg |

Will Consumers Trust Generic Viagra?

A generic version of Viagra is coming to America, but will existing customers be willing to switch over to a…

Paul Ausick |

Viagra for Sale Online: Will Other Drug Companies Follow Pfizer?

Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to…

Viagra Price Drops 50% as Drug Faces Competition
Douglas A. McIntyre |

Viagra Price Drops 50% as Drug Faces Competition

Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved
Jon C. Ogg |

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to…

Douglas A. McIntyre |

Viagra Available Online Soon

Wikimedia CommonsMen, or their significant others, will be able to buy Pfizer Inc.’s (NYSE: PFE) erectile dysfunction drug Viagra online soon.…

Chris Lange |

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?

Top Gaining Stocks

Dell Technologies
DELL • Vol: 42,366,555
NetApp
NTAP • Vol: 15,911,807
ServiceNow
NOW • Vol: 68,243,561
IBM
IBM • Vol: 28,527,546
Hewlett Packard Enterprise
HPE • Vol: 86,996,387

Top Losing Stocks

Coterra Energy
CTRA • Vol: 73,319,495
Clorox
CLX • Vol: 4,744,001
ResMed
RMD • Vol: 3,526,686
Intel
INTC • Vol: 191,680,425
Skyworks Solutions
SWKS • Vol: 5,407,806